EPCAM and breast carcinoma: Tachtsidis et al. examined xenograft models of triple negative (using MDA-MB-468 cell line) and ER-positive (patient derived) breast cancer and showed that low EpCAM and high EMT marker expression in CTCs promoted tumor metastases [145].